Provided By PR Newswire
Last update: Jul 12, 2025
NEW YORK, July 12, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. ("PetMed" or the "Company") (NASDAQ: PETS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Read more at prnewswire.comNASDAQ:PETS (10/30/2025, 8:00:01 PM)
2.52
-0.07 (-2.7%)
Find more stocks in the Stock Screener



